Literature DB >> 23318802

Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae.

Shyamasree De Majumdar1, Mark Veleba, Sarah Finn, Séamus Fanning, Thamarai Schneiders.   

Abstract

RarA is an AraC-type regulator in Klebsiella pneumoniae, which, when overexpressed, confers a low-level multidrug-resistant (MDR) phenotype linked to the upregulation of both the acrAB and oqxAB efflux genes. Increased rarA expression has also been shown to be integral in the development of tigecycline resistance in the absence of ramA in K. pneumoniae. Given its phenotypic role in MDR, microarray analyses were performed to determine the RarA regulon. Transcriptome analysis was undertaken using strains Ecl8ΔrarA/pACrarA-2 (rarA-expressing construct) and Ecl8ΔrarA/pACYC184 (vector-only control) using bespoke microarray slides consisting of probes derived from the genomic sequences of K. pneumoniae MGH 78578 (NC_009648.1) and Kp342 (NC_011283.1). Our results show that rarA overexpression resulted in the differential expression of 66 genes (42 upregulated and 24 downregulated). Under the COG (clusters of orthologous groups) functional classification, the majority of affected genes belonged to the category of cell envelope biogenesis and posttranslational modification, along with genes encoding the previously uncharacterized transport proteins (e.g., KPN_03141, sdaCB, and leuE) and the porin OmpF. However, genes associated with energy production and conversion and amino acid transport/metabolism (e.g., nuoA, narJ, and proWX) were found to be downregulated. Biolog phenotype analyses demonstrated that rarA overexpression confers enhanced growth of the overexpresser in the presence of several antibiotic classes (i.e., beta-lactams and fluoroquinolones), the antifungal/antiprotozoal compound clioquinol, disinfectants (8-hydroxyquinoline), protein synthesis inhibitors (i.e., minocycline and puromycin), membrane biogenesis agents (polymyxin B and amitriptyline), DNA synthesis (furaltadone), and the cytokinesis inhibitor (sanguinarine). Both our transcriptome and phenotypic microarray data support and extend the role of RarA in the MDR phenotype of K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318802      PMCID: PMC3623357          DOI: 10.1128/AAC.01998-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Structural requirements for marbox function in transcriptional activation of mar/sox/rob regulon promoters in Escherichia coli: sequence, orientation and spatial relationship to the core promoter.

Authors:  R G Martin; W K Gillette; S Rhee; J L Rosner
Journal:  Mol Microbiol       Date:  1999-11       Impact factor: 3.501

Review 2.  The AraC transcriptional activators.

Authors:  R G Martin; J L Rosner
Journal:  Curr Opin Microbiol       Date:  2001-04       Impact factor: 7.934

3.  Antimicrobial activities of some amino derivatives of 5,7-dibromo-2-methyl-8-hydroxyquinoline.

Authors:  G B Okide; M U Adikwu; C O Esimone
Journal:  Biol Pharm Bull       Date:  2000-02       Impact factor: 2.233

4.  Tools for characterization of Escherichia coli genes of unknown function.

Authors:  Christophe Merlin; Sean McAteer; Millicent Masters
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

5.  Phenotype microarrays for high-throughput phenotypic testing and assay of gene function.

Authors:  B R Bochner; P Gadzinski; E Panomitros
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

6.  Identification of SoxS-regulated genes in Salmonella enterica serovar typhimurium.

Authors:  P J Pomposiello; B Demple
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

7.  Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA.

Authors:  T M Barbosa; S B Levy
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

8.  Comparison of the Escherichia coli K-12 genome with sampled genomes of a Klebsiella pneumoniae and three salmonella enterica serovars, Typhimurium, Typhi and Paratyphi.

Authors:  M McClelland; L Florea; K Sanderson; S W Clifton; J Parkhill; C Churcher; G Dougan; R K Wilson; W Miller
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

9.  A reducing system of the superoxide sensor SoxR in Escherichia coli.

Authors:  Mi-Sun Koo; Joon-Hee Lee; So-Yeon Rah; Won-Sik Yeo; Jin-Won Lee; Kang-Lok Lee; Young-Sang Koh; Sa-Ouk Kang; Jung-Hye Roe
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Complete genome sequence of the N2-fixing broad host range endophyte Klebsiella pneumoniae 342 and virulence predictions verified in mice.

Authors:  Derrick E Fouts; Heather L Tyler; Robert T DeBoy; Sean Daugherty; Qinghu Ren; Jonathan H Badger; Anthony S Durkin; Heather Huot; Susmita Shrivastava; Sagar Kothari; Robert J Dodson; Yasmin Mohamoud; Hoda Khouri; Luiz F W Roesch; Karen A Krogfelt; Carsten Struve; Eric W Triplett; Barbara A Methé
Journal:  PLoS Genet       Date:  2008-07-25       Impact factor: 5.917

View more
  26 in total

Review 1.  Plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Jacob Strahilevitz; David C Hooper
Journal:  Microbiol Spectr       Date:  2014-10

Review 2.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

3.  Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics.

Authors:  Tânia Curiao; Emmanuela Marchi; Carlo Viti; Marco R Oggioni; Fernando Baquero; José Luis Martinez; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

4.  Rapid antibiotic susceptibility testing based on bacterial motion patterns with long short-term memory neural networks.

Authors:  Rafael Iriya; Wenwen Jing; Karan Syal; Manni Mo; Chao Chen; Hui Yu; Shelley E Haydel; Shaopeng Wang; Nongjian Tao
Journal:  IEEE Sens J       Date:  2020-01-17       Impact factor: 3.301

5.  Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.

Authors:  Matthew E Wand; Lucy J Bock; Laura C Bonney; J Mark Sutton
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 6.  Tetracycline Antibiotics and Resistance.

Authors:  Trudy H Grossman
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

Review 7.  Mechanisms of drug resistance: quinolone resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Ann N Y Acad Sci       Date:  2015-07-17       Impact factor: 5.691

8.  IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae.

Authors:  Lindsey E Nielsen; Erik C Snesrud; Fatma Onmus-Leone; Yoon I Kwak; Ricardo Avilés; Eric D Steele; Deena E Sutter; Paige E Waterman; Emil P Lesho
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

9.  Evaluation of gene expression and protein structural modeling involved in persister cell formation in Salmonella Typhimurium.

Authors:  Negar Narimisa; Fatemeh Amraei; Behrooz Sadeghi Kalani; Faramarz Masjedian Jazi
Journal:  Braz J Microbiol       Date:  2020-10-30       Impact factor: 2.476

10.  Comparative effects of overproducing the AraC-type transcriptional regulators MarA, SoxS, RarA and RamA on antimicrobial drug susceptibility in Klebsiella pneumoniae.

Authors:  Juan-Carlos Jiménez-Castellanos; Wan Nur Ismah Wan Ahmad Kamil; Ching Hei Phoebe Cheung; Maryann S Tobin; James Brown; Sophie G Isaac; Kate J Heesom; Thamarai Schneiders; Matthew B Avison
Journal:  J Antimicrob Chemother       Date:  2016-03-29       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.